PDCD1 and cancer: ILC3s express PD-1 in primary and metastatic tumors,65 and the PD-1/PD-L1 axis in ILC3s regulates cytokines secretion and immune tolerance.77 Although still in its early stages, research into the role of ILCs during checkpoint therapy represents a promising new field for cancer immunotherapy.